Erythema toxicum neonatorum is a harmless, self-resolving skin rash that appears in roughly one in five newborns, typically within the first few days of life. Despite its alarming name, it requires no treatment and leaves no lasting marks. The rash appears to be the newborn immune system’s first reaction to the normal bacteria that colonize the skin after birth, which makes it less a disease and more a sign that the body’s defenses are switching on.
What the Rash Looks Like
The classic appearance is a mix of flat red patches, small raised bumps, and tiny yellow-white pustules, often surrounded by a blotchy red flare. The lesions can pop up almost anywhere on the body but tend to favor the trunk, upper arms, and thighs. The face is sometimes involved, while the palms and soles are almost always spared. The spots can shift location over hours, appearing in one area and fading in another, which can be unnerving for parents who feel like the rash keeps spreading. Each individual spot usually lasts only a day or two before resolving on its own.
Most cases appear between 24 and 72 hours after birth, though some babies develop lesions within the first few hours, and a smaller number see new spots appearing up to about two weeks of age. The baby otherwise looks and acts perfectly healthy: feeding well, alert, and without fever. That combination of a dramatic-looking rash on a baby who seems fine is one of the most reliable clinical clues.
How Common It Is and Who Gets It
Estimates of how many newborns develop erythema toxicum vary depending on how carefully clinicians look for it, but large studies place the prevalence around 20 to 30 percent. A multicenter study of over 2,800 neonates found a prevalence of about 21 percent.1PubMed. Epidemiology and Predisposing Factors for Erythema Toxicum Neonatorum and Transient Neonatal Pustular: A Multicenter Study Some smaller hospital-based surveys have reported figures as high as 50 percent or more, likely because mild cases are easy to miss during a routine newborn exam if nobody is specifically checking for them.
Several factors seem to nudge the odds upward. Full-term babies develop the rash far more often than premature ones, and higher birthweight also correlates with a greater chance of developing lesions.2PubMed. Epidemiology and Predisposing Factors for Erythema Toxicum Neonatorum and Transient Neonatal Pustular: A Multicenter Study Vaginal delivery is associated with a higher rate of the rash compared with cesarean birth, a pattern confirmed in studies across different populations.3PubMed. Prospective study of erythema toxicum neonatorum: epidemiology and predisposing factors 4PubMed. Neonatal Dermatologic Findings in Uruguay: Epidemiology and Predisposing Factors One prospective study also found a higher prevalence in Caucasian newborns compared with other groups.5PubMed. Prospective study of erythema toxicum neonatorum: epidemiology and predisposing factors
These associations actually fit neatly with the leading theory about why the rash happens, which centers on microbial exposure and skin maturity.
Why It Happens
For decades, the cause of erythema toxicum was listed as “unknown” in textbooks. That picture has shifted. Research now strongly suggests the rash is the newborn’s innate immune system reacting to the harmless bacteria that begin colonizing the skin immediately after birth. One influential study found that in every lesion examined, bacteria consistent with common skin staphylococci were present inside the hair follicle lining and had been engulfed by nearby immune cells.6PubMed. Erythema toxicum neonatorum is an innate immune response to commensal microbes penetrated into the skin of the newborn infant The same study noted that newborn skin has roughly ten times more hair structures per unit of surface area than adult skin, creating many more entry points for microbes to slip beneath the surface.
This helps explain the risk-factor pattern. Babies born vaginally are drenched in their mother’s microbial flora during delivery, giving them an earlier and heavier dose of skin colonization. Premature babies, whose skin barrier is less mature and who are often kept in isolettes with reduced microbial exposure, develop the rash less frequently. And full-term babies with higher birthweight tend to have better-developed immune responses, primed to react more vigorously when those first bacteria arrive.
A review of the newborn skin microbiome described erythema toxicum as “an immune response to the establishment of normal bacterial skin flora,” placing it squarely in the category of healthy immune activation rather than disease.7PubMed. The infantile cutaneous microbiome: A review Infants with the rash also tend to run slightly higher body temperatures, consistent with a mild, systemic immune response rather than an infection.8PubMed. Erythema toxicum neonatorum is an innate immune response to commensal microbes penetrated into the skin of the newborn infant
What Is Going On Under the Skin
If you could look at an erythema toxicum lesion under a microscope, the hallmark finding is a dense cluster of eosinophils, a type of white blood cell usually associated with allergic reactions and parasitic infections, concentrated around the hair follicle just below the skin surface.9Pediatrics. HISTOLOGIC OBSERVATIONS IN ERYTHEMA TOXICUM NEONATORUM When the rash progresses to a small pustule, those eosinophils have migrated up into the outer layer of skin surrounding the hair shaft. Other immune cells are recruited too: studies using tissue staining techniques have identified dendritic cells, neutrophils, and macrophages crowded into the lesion site, along with strong activation of E-selectin, a molecule that helps immune cells stick to blood vessel walls and crawl toward the action.10PubMed. Erythema toxicum neonatorum: an immunohistochemical analysis
The immune cells at the site are not just showing up passively. Biopsies from the lesions reveal that these cells are actively producing antimicrobial peptides, small proteins that punch holes in bacterial membranes. One study found that the peptide LL-37 was being made inside the neutrophils, eosinophils, and dendritic cells present in the rash, and that another antimicrobial peptide called human beta-defensin-1 was constitutively present in the affected skin.11British Journal of Dermatology. The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa In plain terms, the baby’s skin is not just inflamed for no reason. It is deploying chemical weapons against the bacteria it has just met for the first time, a process that is loud and visible but ultimately beneficial.
Why It Matters to Tell It Apart From Serious Rashes
The real clinical importance of erythema toxicum is not the rash itself but the need to distinguish it from conditions that do require urgent treatment. Several other newborn skin conditions look confusingly similar, and at least one is a medical emergency.
Neonatal herpes simplex virus infection is the most concerning mimic. Herpes can produce vesicles and pustules on a red base, which at a glance may resemble erythema toxicum. Several features help separate the two. Herpes lesions tend to appear a bit later, usually between 6 and 13 days of age, compared with the first few days for erythema toxicum. Herpes vesicles are often larger, grouped in tight clusters, and the baby may have a fever or appear genuinely unwell.12Global Journal of Pediatrics & Neonatal Care. Neonate with Clustered Pustules on an Erythematous Base, A Diagnostic Dilemma A history of maternal herpes infection, especially a primary outbreak near delivery, raises the suspicion further. Because untreated neonatal herpes can be devastating, clinicians are rightly cautious: when there is any real doubt, antiviral treatment is started while tests are pending rather than waiting for confirmation.
Other benign rashes that overlap in appearance include transient neonatal pustular melanosis, which tends to be present at birth rather than appearing a day or two later and leaves behind small pigmented spots when the pustules rupture, and benign cephalic pustulosis, which clusters on the face and scalp. All three of these benign newborn rashes are self-limited and need no treatment.13PubMed Central. Benign skin disease with pustules in the newborn The challenge is not treating these conditions but making sure nothing dangerous is masquerading as something harmless.
Do Any Tests Need to Be Done?
In a classic presentation, no laboratory testing is required. An experienced clinician can usually diagnose erythema toxicum by its appearance combined with the baby’s overall good health. If there is doubt, a quick and simple test can help: a smear of fluid from inside a pustule, stained with a Wright or Giemsa stain, will show a predominance of eosinophils. That finding is essentially diagnostic and rules out bacterial infection, in which neutrophils would dominate instead.
A full blood count drawn from a baby with erythema toxicum sometimes shows a mild increase in circulating eosinophils, which is consistent with the local eosinophilic response happening in the skin. This peripheral eosinophilia is transient and requires no follow-up. The one scenario where further workup becomes necessary is when the rash does not fit the textbook pattern: if lesions persist beyond two weeks, if the baby shows signs of systemic illness, or if the pustules look more like grouped vesicles, a sepsis evaluation or viral testing may be warranted.
Does It Need Treatment?
No. The rash resolves completely on its own, typically within one to two weeks, without scarring or pigment changes. No creams, antibiotics, antihistamines, or home remedies are necessary. In fact, some of the things parents instinctively want to try, like applying alcohol-based solutions, fragrant lotions, or scrubbing at the spots, can irritate delicate newborn skin and cause more problems than the rash itself.
The most useful intervention is reassurance. Studies consistently describe parental anxiety as the main “complication” of erythema toxicum. A baby covered in blotchy red spots and tiny pus-filled bumps looks alarming, and the name itself, with “toxicum” right there in it, does not help. Many parents understandably worry about infection, allergy, or a reaction to something they did or used. A clear, confident explanation from a healthcare provider that the rash is a normal part of the newborn period and carries no long-term consequences is the only treatment most families need.
Why the Name Is So Misleading
The term “erythema toxicum” dates back centuries and reflects an era when any unexplained skin eruption in a newborn was assumed to be the body purging toxins absorbed in the womb. The word “toxicum” implies poison, which is exactly the wrong message for anxious parents. Various attempts to rename the condition to something less frightening, such as “erythema neonatorum” or “neonatal erythema,” have never fully caught on in clinical practice. The old name persists in textbooks, hospital discharge summaries, and internet search results, which means parents often encounter it and reasonably assume something toxic is happening to their baby.
If anything, the emerging science suggests the opposite of toxicity. The rash appears to reflect the immune system doing precisely what it should, recognizing and responding to the microbes that will eventually form the baby’s permanent skin microbiome. Some researchers have even speculated that the rash may play a protective role, with the antimicrobial peptides produced during the reaction helping to control bacterial colonization during the vulnerable first days of life. That idea is still more hypothesis than proven fact, but it reframes the condition from a mysterious eruption into a plausible part of normal immune development.
The Vaginal Delivery Connection
The consistently higher rates of erythema toxicum in vaginally delivered babies deserve a closer look, because the pattern reveals something about how we are colonized by microbes in the first moments of life. During vaginal delivery, the baby is coated in the mother’s vaginal and perineal bacteria, which immediately begin populating the skin. Babies born by cesarean section, by contrast, tend to be colonized first by bacteria from the hospital environment and from skin-to-skin contact with caregivers, a process that is slower and produces a different initial microbial community.
If erythema toxicum is driven by the immune system’s first encounter with skin bacteria, then earlier and denser colonization after vaginal delivery logically produces more robust reactions. This is consistent with the observation that the rash is also less common in very premature infants, who spend their early days in incubators with controlled environments and reduced microbial exposure. In a sense, erythema toxicum may be a byproduct of normal, healthy microbial seeding, and its absence in certain populations may reflect atypical colonization patterns rather than a healthier state.
Traditional Newborn Skin Practices
Across many cultures, newborn skin conditions have long been targets for traditional remedies, and erythema toxicum is no exception. In parts of the Middle East, for example, some families practice salt-rubbing of newborns shortly after birth, sometimes followed by application of olive oil. One study documenting rural Jordanian practices found that families would dissolve salt in water and rub it on the baby, particularly in skin folds, with olive oil applied afterward to soothe the skin.14PubMed Central. Traditional Practices Adopted by Jordanian Mothers When Caring for Their Infants in Rural Areas Similar practices, including applications of mustard oil, turmeric paste, or herbal preparations, have been documented in South Asian and African communities.
These traditions predate the scientific understanding that erythema toxicum is benign and self-resolving. When a newborn develops a conspicuous rash, the instinct to intervene is powerful, and cultural practices fill that gap with action. The concern from a medical standpoint is not that these practices are attempting to treat something that doesn’t need treating, though that is true, but that some of them can damage the delicate skin barrier. Salt, for instance, is irritating to newborn skin and can cause dryness and microabrasions. Mustard oil has been associated with impaired skin barrier function in neonates. Healthcare providers working with families who practice these traditions face the delicate task of respecting cultural context while steering parents away from interventions that could harm fragile skin.
Can It Come Back or Happen Twice?
Erythema toxicum is almost exclusively a newborn phenomenon. Once it resolves, it does not recur. A baby who had it with one delivery will not develop it again at some later point in childhood. However, because the rash can wax and wane over its brief lifespan, with new spots appearing as old ones fade, parents sometimes perceive it as a recurrence when it is really the same episode evolving. If a rash with a similar appearance develops outside the newborn period, it is something else entirely and should be evaluated on its own terms.
There is also no evidence that having erythema toxicum as a newborn predicts any later skin condition. It does not increase the risk of eczema, allergies, or any other dermatologic problem down the line. The eosinophilic nature of the rash sometimes prompts parents to worry about allergic tendencies, since eosinophils are involved in both. But the eosinophilic response in erythema toxicum is a brief, localized reaction to microbial colonization, not a marker of the chronic immune dysregulation that underlies atopic disease. Reassuringly, no longitudinal study has linked the two.